Publication
An in vivo evaluation of the potential of 188Re-PEI-MP for therapy of bladder carcinoma and 99mTc-PEI-MP for diagnosis and follow up
| dc.contributor.author | Ferreira, Sara | |
| dc.contributor.author | Laranjo, Mafalda | |
| dc.contributor.author | Abrantes, Ana Margarida | |
| dc.contributor.author | Brito, Ana | |
| dc.contributor.author | Pires, Salomé | |
| dc.contributor.author | Metello, Luís F. | |
| dc.contributor.author | Zeevart, Jan | |
| dc.contributor.author | Louw, Werner | |
| dc.contributor.author | Dormehl, Irene | |
| dc.contributor.author | Botelho, Maria Filomena | |
| dc.date.accessioned | 2015-07-09T16:03:06Z | |
| dc.date.available | 2015-07-09T16:03:06Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | The development of water-soluble polymers such as PEI-MP (polyethyleneimine, functionalised with methylphosphonate groups) that might be labeled with 188Re (emits of high energy beta particles) and 99mTc are recent approaches, with a strong potential for metabolic radiotherapy and diagnosis, respectively. The aim of this study was to evaluate the efficacy of 188Re-PEI-MP as therapeutic agent for bladder carcinoma and 99mTc-PEI-MP for its diagnosis and follow up. | en |
| dc.identifier.uri | http://hdl.handle.net/10400.22/6457 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Oxford University Press | por |
| dc.title | An in vivo evaluation of the potential of 188Re-PEI-MP for therapy of bladder carcinoma and 99mTc-PEI-MP for diagnosis and follow up | por |
| dc.type | other | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 30 | por |
| oaire.citation.startPage | 30 | por |
| oaire.citation.title | Annals of Oncology - Targeted Anticancer Therapies | por |
| oaire.citation.volume | 23 | por |
| rcaap.rights | openAccess | por |
| rcaap.type | other | por |